SANDCAT
Jan 23 2023
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients with Uveitic Macular Edema (Sandcat)
Read MoreCapriCORN
Jan 23 2023
Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory-markers in the Cornea
Read MoreRECORDATI MT8
Jan 23 2023
Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops (MT8) for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients
Read More
DOVS Researchers Develop New Therapies for Retinal Disorders
Feb 15 2021
Using a nucleic acid-based therapy to target genetic mutations, eye researchers at the University of Wisconsin–Madison and University of Iowa will develop and test a new therapy for restoring vision in children and adults with…
Read More